Skip to main content
Clinical Trials/CTRI/2020/05/025239
CTRI/2020/05/025239
Not yet recruiting
Phase 1

A PHARMACO-CLINICAL STUDY FOR EVALUATION OF SHILAJATU FOR PREVENTIVE AND CURATIVE MANAGEMENT OF ASHMARI W.S.R. TO UROLITHIASIS - UroShil

ational Institute of Ayurveda Jaipur0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda Jaipur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Eligibility Criteria

Inclusion Criteria

  • Patient with features urolithiasis and evidence of stone in kidney/ureter/bladder (KUB) less than 15 mm in size

Exclusion Criteria

  • Patients below 18 years and above 60 years, Patient having renal stone size \>15mm or stone at lower calyx of kidney, Patients with severe complications such as hydroureteronephrosis, upper urinary tract infections, renal insufficiency, and are requiring immediate or urgent intervention, Patients suffering from serious systemic disorders such as Diabetes mellitus, Hypertension etc. or any history of hypersensitivity to any herbal formulation, Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials